These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32419517)

  • 1. Emerging therapies for COVID-19 pneumonia.
    Battaglini D; Robba C; Ball L; Cruz FF; Silva PL; Pelosi P; Rocco PRM
    Expert Opin Investig Drugs; 2020 Jul; 29(7):633-637. PubMed ID: 32419517
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical Toxicology and COVID-19: Our Role in a Pandemic.
    Neumann NR; Chai PR; Wood DM; Greller HA; Mycyk MB
    J Med Toxicol; 2020 Jul; 16(3):245-247. PubMed ID: 32356251
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.
    Saavedra JM
    Pharmacol Res; 2020 Sep; 159():104958. PubMed ID: 32473311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for the Treatment of Elderly Patients with COVID-19 from the Taskforce for Gerontopneumology].
    Stieglitz S; Frohnhofen H; Netzer N; Haidl P; Orth M; Schlesinger A
    Pneumologie; 2020 Aug; 74(8):505-508. PubMed ID: 32434253
    [No Abstract]   [Full Text] [Related]  

  • 5. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with Dexamethasone in Patients with COVID-19 - A Position Paper of the German Respiratory Society (DGP)].
    Kolditz M; Dellweg D; Geerdes-Fenge H; Lepper PM; Schaberg T; Ewig S; Pfeifer M; Bauer T
    Pneumologie; 2020 Aug; 74(8):493-495. PubMed ID: 32674177
    [No Abstract]   [Full Text] [Related]  

  • 7. Can beta-adrenergic blockers be used in the treatment of COVID-19?
    Vasanthakumar N
    Med Hypotheses; 2020 Sep; 142():109809. PubMed ID: 32388480
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
    Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
    Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging cardiological issues during the COVID-19 pandemic.
    Everaert BR; Muylle J; Bartholomeus Twickler T
    Eur J Clin Invest; 2020 Jul; 50(7):e13270. PubMed ID: 32415992
    [No Abstract]   [Full Text] [Related]  

  • 10. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
    Huang Y; Xie C; Chen X; Hong Q; Huang H
    Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.
    Isidori AM; Pofi R; Hasenmajer V; Lenzi A; Pivonello R
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):472-473. PubMed ID: 32334645
    [No Abstract]   [Full Text] [Related]  

  • 12. Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
    Nawar T; Morjaria S; Kaltsas A; Patel D; Perez-Johnston R; Daniyan AF; Mailankody S; Parameswaran R
    Am J Hematol; 2020 Aug; 95(8):E210-E213. PubMed ID: 32419212
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology and treatment strategies for COVID-19.
    Kumar M; Al Khodor S
    J Transl Med; 2020 Sep; 18(1):353. PubMed ID: 32933536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 16. Dexamethasone for COVID-19: preliminary findings.
    Drug Ther Bull; 2020 Sep; 58(9):133. PubMed ID: 32690491
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of medications used to control and improve the signs and symptoms of COVID-19 patients.
    Hushmandi K; Bokaie S; Hashemi M; Moghadam ER; Raei M; Hashemi F; Bagheri M; Habtemariam S; Nabavi SM
    Eur J Pharmacol; 2020 Nov; 887():173568. PubMed ID: 32956644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.
    Song Y; Liu P; Shi XL; Chu YL; Zhang J; Xia J; Gao XZ; Qu T; Wang MY
    Gut; 2020 Jun; 69(6):1143-1144. PubMed ID: 32139552
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronavirus disease 2019 infection and the cardiovascular system.
    Romeo F; Calcaterra G; Barilla F; Mehta JL
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):403-405. PubMed ID: 32324641
    [No Abstract]   [Full Text] [Related]  

  • 20. An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the US.
    DeJong C; Chen AH; Lo B
    JAMA; 2020 Jun; 323(23):2367-2368. PubMed ID: 32412580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.